Insider Transactions in Q3 2024 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2024
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.84%
|
$82,500
$11.71 P/Share
|
|
Sep 03
2024
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.83%
|
$60,000
$8.61 P/Share
|
|
Aug 21
2024
|
Simon N.R. Harford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,529
-7.62%
|
$150,348
$12.09 P/Share
|
|
Aug 01
2024
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.84%
|
$75,000
$10.34 P/Share
|
|
Aug 01
2024
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.83%
|
$60,000
$8.61 P/Share
|
|
Jul 05
2024
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
6,100
-0.68%
|
$61,000
$10.0 P/Share
|
|
Jul 05
2024
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,100
+0.68%
|
$48,800
$8.61 P/Share
|
|
Jul 01
2024
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
1,400
-0.16%
|
$14,000
$10.0 P/Share
|
|
Jul 01
2024
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+0.16%
|
$11,200
$8.61 P/Share
|